Showing all 10 results

  • Adbry tralokinumab ldrm
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Adbry (tralokinumab-ldrm) Online For Sale

    $1,309.00

    DISEASE INDICATIONS: Atopic Dermatitis

    MANUFACTURER: Leo Pharma

    USAGE: Subcutaneous

    MEDICINE APPROVED BY:

    Food and Drug Administration (FDA)

    Adbry (tralokinumab-ldrm) is a biologic medication used to treat moderate to severe eczema in adults by inhibiting the inflammatory protein, interleukin-13. It is administered as a subcutaneous injection, and initial loading doses are followed by maintenance doses every four weeks. Adbry should be stored in a refrigerator, and patients should inform their doctor of any infections or weakened immune systems.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Cibinqo abrocitinib
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Cibinqo (abrocitinib) Online For Sale

    From $1,262.10

    DISEASE INDICATIONS: Atopic Dermatitis

    MANUFACTURER: Pfizer Limited

    USAGE: Oral

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Pharmaceuticals and Medical Devices Agency (PMDA)

    Medicines & Healthcare products Regulatory Agency (MHRA)

    Cibinqo (abrocitinib) is a medication used to treat moderate to severe atopic dermatitis in adults by blocking JAK enzymes in the body that cause inflammation.

    Select options This product has multiple variants. The options may be chosen on the product page
  • In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Ilumya (tildrakizumab) Online For Sale

    DISEASE INDICATIONS: Psoriasis

    MANUFACTURER: Almirall, S.A.

    USAGE: Subcutaneous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Ilumya (tildrakizumab) is a prescription medication that treats moderate to severe plaque psoriasis in adults by selectively targeting IL-23 to reduce inflammation and skin cell proliferation.

    Read more
  • Olumiant baricitinib
    In Stock
    Add to Wishlist
    Compare
    Quick View
    , ,

    Buy Olumiant (baricitinib) Online For Sale

    From $1,048.95

    DISEASE INDICATIONS: Rheumatoid Arthritis

    MANUFACTURER: Eli Lilly Nederland B.V.

    USAGE: Oral

    MEDICINE APPROVED BY: European Medical Agency (EMA)

    Olumiant (baricitinib) is an oral medication that inhibits the activity of Janus kinases to reduce inflammation and improve joint pain, swelling, and stiffness in adults with moderate to severe rheumatoid arthritis.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Skilarence dimethyl fumarate
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Skilarence (dimethyl fumarate) Online For Sale

    From $91.35

    DISEASE INDICATIONS: Psoriasis

    MANUFACTURER: Almirall, S.A.

    USAGE: Oral

    MEDICINE APPROVED BY: European Medical Agency (EMA)

    Skilarence is a medication prescribed to treat moderate to severe plaque psoriasis in adult patients. It comes in oral capsule form and reduces inflammation in the body by activating a transcription factor called Nrf2.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Skyrizi risankizumab abbvie
    In Stock
    Add to Wishlist
    Compare
    Quick View
    ,

    Buy Skyrizi (Risankizumab) Online For Sale

    From $14,227.50

    DISEASE INDICATIONS:Psoriasis

    MANUFACTURER:AbbVie Ltd

    USAGE:Subcutaneous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Therapeutic Goods Administration (TGA)

    Skyrizi is a prescription medication that treats moderate to severe plaque psoriasis in adult patients by blocking a protein called interleukin-23.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Spevigo spesolimab sbzo
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Spevigo (spesolimab-sbzo) Online For Sale

    DISEASE INDICATIONS: Psoriasis

    MANUFACTURER: Boehringer Ingelheim

    USAGE: Intravenous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Spevigo is a prescription medication that treats moderate to severe plaque psoriasis in adults by blocking interleukin-31.

    Read more
  • Takhzyro lanadelumab
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Takhzyro (lanadelumab) Online For Sale

    $13,774.95

    DISEASE INDICATIONS: Hereditary angioedema (HAE)

    MANUFACTURER: Shire Pharmaceuticals

    USAGE: Subcutaneous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Takhzyro is a prescription medication used to prevent swelling caused by hereditary angioedema (HAE) in individuals aged 12 years and older. It works by blocking kallikrein, a protease involved in the pathophysiology of HAE.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Taltz ixekizumab
    In Stock
    Add to Wishlist
    Compare
    Quick View
    ,

    Buy Taltz (ixekizumab) Online For Sale

    From $2,449.65

    DISEASE INDICATIONS:Psoriasis

    MANUFACTURER:Eli Lilly Nederland B.V.

    USAGE:Subcutaneous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Health Canada

    Therapeutic Goods Administration (TGA)

    Taltz (ixekizumab) is a medication used to treat moderate-to-severe plaque psoriasis, active psoriatic arthritis, and active ankylosing spondylitis.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Zoryve roflumilast
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Zoryve (roflumilast) Online For Sale

    $1,005.90

    DISEASE INDICATIONS: Psoriasis

    MANUFACTURER: Arcutis Biotherapeutics, Inc.

    USAGE: Cutaneous

    MEDICINE APPROVED BY:

    Food and Drug Administration (FDA)

    Zoryve (roflumilast) is a medication used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, in adults with severe COPD and a history of exacerbations.

    Select options This product has multiple variants. The options may be chosen on the product page